64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 4, 2015, Pages 1161-1166

  Griessinger, Christoph M ^a   Maurer, Andreas ^a   Kesenheimer, Christian ^a   Kehlbach, Rainer ^a   Reischl, Gerald ^a   Ehrlichmann, Walter ^a   Bukala, Daniel ^a   Harant, Maren ^a   Cay, Funda ^a   Brück, Jürgen ^a   Nordin, Renate ^a   Kohlhofer, Ursula ^a   Rammensee, Hans Georg ^a,b   Quintanilla Martinez, Leticia ^a   Schaller, Martin ^a   Röcken, Martin ^a   Pichler, Bernd J ^a   Kneilling, Manfred ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Airway DTHR; Antibody based cell labeling; In vivo cell tracking; Mouse T cells; PET imaging

Indexed keywords

COPPER 64; DNA; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; OVALBUMIN; T LYMPHOCYTE RECEPTOR; COPPER; LYMPHOCYTE ANTIGEN RECEPTOR; TRACER;

ALLERGIC REACTION; ANIMAL BEHAVIOR; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; DNA DAMAGE; ENDOCYTOSIS; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INTERNALIZATION; LYMPH NODE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TURNOVER TIME; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNOLOGY; PROCEDURES; RADIOGRAPHY;

MAMMALIA; MUS;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; COPPER RADIOISOTOPES; DNA DAMAGE; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RECEPTORS, ANTIGEN; T-LYMPHOCYTES;

EID: 84921797310     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1418391112     Document Type: Article

References (27)

1. Ahrens ET, Bulte JW (2013) Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 13(10):755-763.
2. Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: Harnessing the T cell response. Nat Rev Immunol 12(4):269-281.
3. Lafaille JJ (1998) The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 9(2):139-151.
4. Müller-Hermelink N, et al. (2008) TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13(6):507-518.
5. Muranski P, Restifo NP (2009) Adoptive immunotherapy of cancer using CD4(+) T cells. Curr Opin Immunol 21(2):200-208.
6. Braumüller H, et al. (2013) T-helper-1-cell cytokines drive cancer into senescence. Nature 494(7437):361-365.
7. Adonai N, et al. (2002) Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 99(5):3030-3035.
8. Prince HM, et al. (2008) In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother 31(2):166-179.
9. Huang J, Lee CC, Sutcliffe JL, Cherry SR, Tarantal AF (2008) Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imaging 7(1):1-11.
10. Griessinger CM, et al. (2014) In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J NuclMed 55(2):301-307.
11. Shimonkevitz R, Kappler J, Marrack P, Grey H (1983) Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 158(2):303-316.
12. Hanahan D (1985) Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315(6015): 115-122.
13. Förster I, Hirose R, Arbeit JM, Clausen BE, Hanahan D (1995) Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen. Immunity 2(6):573-585.
14. Balagopalan L, Barr VA, Samelson LE (2009) Endocytic events in TCR signaling: Focus on adapters in microclusters. Immunol Rev 232(1):84-98.
15. Geisler C (2004) TCR trafficking in resting and stimulated T cells. Crit Rev Immunol 24(1):67-86.
16. Schwab I, Nimmerjahn F (2013) Intravenous immunoglobulin therapy: How does IgG modulate the immune system? Nat Rev Immunol 13(3):176-189.
17. Botti C, et al. (1997) Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med 24(5):497-504.
18. Suntharalingam G, et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355(10):1018-1028.
19. Yudushkin IA, Vale RD (2010) Imaging T-cell receptor activation reveals accumulation of tyrosine-phosphorylated CD3ζ in the endosomal compartment. Proc Natl Acad Sci USA 107(51):22128-22133.
20. Chakrabarti MC, Le N, Paik CH, De Graff WG, Carrasquillo JA (1996) Prevention of radiolysis of monoclonal antibody during labeling. J Nucl Med 37(8):1384-1388.
21. Ostrakhovitch EA, CherianMG (2005) Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF)mediated apoptosis in epithelial breast cancer cells: The lack of effect of ERK in p53 mediated copper induced apoptosis. J Cell Biochem 95(6): 1120-1134.
22. Haldsrud R, Krokje A (2009) Induction of DNA double-strand breaks in the H4IIE cell line exposed to environmentally relevant concentrations of copper, cadmium, and zinc, singly and in combinations. J Toxicol Environ Health A 72(3-4):155-163.
23. Roos WP, Kaina B (2013) DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332(2):237-248.
24. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA (2003) Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 49(6):1006-1013.
25. Bulte JW, et al. (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 96(26):15256-15261.
26. Wolf P, et al. (2010) Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer. Prostate 70(5):562-569.
27. Tavaré R, et al. (2014) Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. Proc Natl Acad Sci USA 111(3):1108-1113.